# Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia

> **NCT00368927** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 61 (actual)

## Conditions studied

- Precancerous Condition
- Stage I Non-small Cell Lung Cancer
- Tobacco Use Disorder

## Interventions

- **DRUG:** sulindac
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00368927
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2010-05
- **Final completion:** 2010-12
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2014-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00368927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00368927, "Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00368927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*